The company has launched two products, DEXYCU and YUTIQ. Both have very substantial market potential, and orders are ramping fast. Due to a situation with its distributor, the ramp in orders hasn’t translated into an acceleration in revenue. Quite the contrary, in fact. This disconnect between orders and revenue is clouding the assessment on how […]
Entries Tagged as 'EYPT'
December 10th, 2019 · Comments Off on EyePoint Pharmaceuticals Faces A Big Opportunity
August 31st, 2019 · Comments Off on EyePoint Pharmaceuticals Is Eyeing 2 Big Market Opportunities
EyePoint Pharmaceuticals has just introduced two new treatments, YUTIQ and DEXYCU, both involve the slow release of steroids to prevent eye infections. Most of the elements for successful market penetration are already in place, and these markets are substantial. Depending on the speed of growth, the company might need another financing. While speculative, it’s a […]